Abstract
Glioma is one of the most common solid tumors, and the molecular mechanism for this disease is poorly understood. EphB4 tyrosine kinase receptor has been involved in various physiologic and pathologic processes, and the role of EphB4 in tumorigenesis has recently attracted much interest. However, its function in glioma remains largely unknown. In this study, we explored the function of EphB4 in glioma. We found that the expression of EphB4 was significantly upregulated in clinical glioma samples. Overexpression of EphB4 in glioma cell lines accelerated cell growth and tumorigenesis. In contrast, downregulation of EphB4 inhibited cell growth. Furthermore, we showed that EphB4 promoted cell growth by promoting EGFR signaling. Taken together, our findings suggest that EphB4 plays an important role in the progression of glioma by stimulating cell growth and EphB4 might be a potential therapeutic target for glioma.
Similar content being viewed by others
References
Siegel R. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.
Marumoto T, Saya H. Molecular biology of glioma. Adv Exp Med Biol. 2012;746:2–11.
Furnari FB, Huang HJ, Cavenee WK. Genetics and malignant progression of human brain tumours. Cancer Surv. 1995;25:233–75.
Eph Nomenclature Committee. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell. 1997;90:403–4.
Palmer A, Klein R. Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. Genes Dev. 2003;17:1429–50.
Wilkinson DG. Eph receptors and ephrins: regulators of guidance and assembly. Int Rev Cytol. 2000;196:177–244.
Zhang J, Hughes S. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol Neurosci. 2006;208:453–61.
Noren NK, Lu M, Freeman AL, et al. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A. 2004;101:5583–8.
Yang NY, Pasquale EB, Owen LB, et al. The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through rho-mediated actin cytoskeleton reorganization. J Biol Chem. 2006;281:32574–86.
Noren NK, Foos G, Hauser CA, et al. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol. 2006;8:815–25.
Tan X, Apte U, Micssenyi A, et al. Epidermal growth factor receptor: a novel target of the Wnt/β-Catenin pathway in liver. Gastroenterology. 2005;129:285–302.
Kumar SR, Singh J, Xia G, et al. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol. 2006;169:279–93.
Clevers H, Batlle E. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer Res. 2006;66:2–5.
Petalk I, et al. Integrating molecular diagnostics into anticancer drug discovery. Nat Rev Drug Disc. 2010;9:523–35.
Mirkin B, et al. Inhibition of human glioma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B. Cell Prolif. 2002;35:105–15.
Ho R, et al. Proliferation of human gliomas mediated by the epidermal growth factor receptor. Cancer Res. 2005;65:9868–75.
Li J, Liu D, Liu G, et al. EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor. Oncogene. 2009;28:1759–68.
Acknowledgments
This work was supported in part by the key laboratory construction grant (no. SW201110010) from Science, Industry, Trade and Information Technology Commission of Shenzhen Municipality, and by the grants from the Shanghai Science and Technology Development Fund (10JC1409802), the Scientific Research and Innovation of Shanghai Municipal Education Commission (11YZ50), and the Wu Jieping Medical Foundation (320.6750.11092).
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Chen, T., Liu, X., Yi, S. et al. EphB4 is overexpressed in gliomas and promotes the growth of glioma cells. Tumor Biol. 34, 379–385 (2013). https://doi.org/10.1007/s13277-012-0560-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-012-0560-7